Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAPAGLIFLOZIN vs DARIDOREXANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DAPAGLIFLOZIN vs DARIDOREXANT: Safety Overview

Metric DAPAGLIFLOZIN DARIDOREXANT
Total FAERS Reports 21,367 2,016
Deaths Reported 3,633 38
Death Rate 17.0% 1.9%
Hospitalizations 8,467 77
Average Patient Age 64.9 yrs 59.4 yrs
% Female Patients 44.5% 65.1%
FDA Approval Date Jan 8, 2014 Apr 7, 2022
Manufacturer AstraZeneca Pharmaceuticals LP N/A
Route ORAL N/A
Marketing Status Prescription Prescription